GDMH join forces with Biotechnology Company Ascelia Pharma, which envisions the co-creation and co-development activities on the SPARKLE study held at Fondazione Policlinico Universitario A. Gemelli IRCCS. Ascelia Pharma, a biotech focused on improving the life of people living with rare cancer conditions is conducting the pivotal Phase 3 clinical studySPARKLE with the candidate drug Orviglance, […]

In its quest to empower medical practice with digital medicine solutions, GDMH announces a collaboration with advisory firm EY for the implementation of state-of-the-art blockchain technology in support of its digital platform construction. EY  is a muldisciplinary professional services organization. Its integrated services include Assurance, Advisory, Tax & Law and Strategy & Transactions.

In its quest to empower medical practice with digital medicine solutions, GDMH announces a collaboration with SAS, a leader company in analytics, which provides innovative software and services to improve performance through data and the application of artificial intelligence. At the core of this collaboration, lies the implementation of the Sandbox platform, already in use at Gemelli Generator